Mixed N‐heterocyclic carbene‐substituted phosphine and phosphite complexes of rhodium were prepared, starting from [Rh(COE)2Cl]2 (COE=cyclooctene) by addition of free N‐heterocyclic carbenes (NHC) and PR3. All new complexes were characterized by spectroscopy. In addition, the structures of trans‐chloro(1,3‐dicyclohexylimidazol‐2‐ylidene)‐bis(triphenylphosphite)rhodium(I) (5), chloro‐trans‐bis(1,3‐dicyclohexylimidazol‐2‐ylidene) (triphenylphosphine)rhodium(I) (6), and chloro(η4‐1,5‐cyclooctadiene)(1,3‐di‐[(1R,2S,5R)‐2‐isopropyl‐5‐menthylcyclohex‐1‐yl]imidazol‐2‐ylidene)rhodium(I) (8) were determined by single crystal X‐ray analyses. The hydrogenation of cyclohexene using molecular hydrogen has been optimized for some N‐heterocyclic carbene‐substituted phosphine and phosphite rhodium complexes by variation of the reaction conditions.
No takes yet. Share an insight, caveat, or question.
Herrmann et al. (2007) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: